• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超生理浓度的5-氨基乙酰丙酸在溶液中通过质子化二氢吡嗪中间体二聚化以产生超氧自由基阴离子。

Supraphysiological concentrations of 5-aminolevulinic acid dimerize in solution to produce superoxide radical anions via a protonated dihydropyrazine intermediate.

作者信息

Hunter Gregory A, Rivera Edwin, Ferreira Gloria C

机构信息

Department of Biochemistry and Molecular Biology, College of Medicine, University of South Florida, Tampa, FL 33612, USA.

出版信息

Arch Biochem Biophys. 2005 May 15;437(2):128-37. doi: 10.1016/j.abb.2005.03.007. Epub 2005 Mar 22.

DOI:10.1016/j.abb.2005.03.007
PMID:15850552
Abstract

5-aminolevulinic acid (ALA) is the committed biological precursor to porphyrins. At supraphysiological concentrations ALA can dimerize to form 3,6-dihydropyrazine-2,5-dipropanoic acid (DHPY), which transfers electrons to XTT in a reaction that does not require metal ions and is specifically inhibited by superoxide dismutase. The formation of DHPY from ALA follows dimerization kinetics with a pK of 7.8+/-0.1. At pH 11.2, DHPY is relatively stable, but when the pH is dropped to 6.0 rapid conversion to 2,5-(beta-carboxyethyl)pyrazine occurs via an intermediate with an absorption maximum of 370 nm. Formation of this intermediate is pH-dependent with a pK of 6.0+/-0.1. These data indicate that ALA dimerizes to produce superoxide from a protonated form of DHPY. The significance of these results with respect to the concentrations of ALA used in photodynamic therapy, and the increased incidence of liver cancer in acute intermittent porphyria, is discussed.

摘要

5-氨基乙酰丙酸(ALA)是卟啉的特定生物前体。在超生理浓度下,ALA可二聚形成3,6-二氢吡嗪-2,5-二丙酸(DHPY),后者在一个不需要金属离子且受超氧化物歧化酶特异性抑制的反应中将电子转移给XTT。从ALA形成DHPY遵循二聚动力学,其pK为7.8±0.1。在pH 11.2时,DHPY相对稳定,但当pH降至6.0时,它会通过一个最大吸收波长为370 nm的中间体快速转化为2,5-(β-羧乙基)吡嗪。该中间体的形成取决于pH,其pK为6.0±0.1。这些数据表明,ALA二聚可从DHPY的质子化形式产生超氧化物。本文讨论了这些结果对于光动力疗法中使用的ALA浓度以及急性间歇性卟啉症中肝癌发病率增加的意义。

相似文献

1
Supraphysiological concentrations of 5-aminolevulinic acid dimerize in solution to produce superoxide radical anions via a protonated dihydropyrazine intermediate.超生理浓度的5-氨基乙酰丙酸在溶液中通过质子化二氢吡嗪中间体二聚化以产生超氧自由基阴离子。
Arch Biochem Biophys. 2005 May 15;437(2):128-37. doi: 10.1016/j.abb.2005.03.007. Epub 2005 Mar 22.
2
DNA damage by 3,6-dihydropyrazine-2,5-dipropanoic acid, the cyclic dimerization product of 5-aminolevulinic acid.
Biol Chem. 2001 Jun;382(6):913-8. doi: 10.1515/BC.2001.113.
3
Reaction of acetaldehyde with 5-aminolevulinic acid via dihydropyrazine derivative.乙醛通过二氢吡嗪衍生物与5-氨基乙酰丙酸的反应。
Chem Pharm Bull (Tokyo). 2015;63(2):126-9. doi: 10.1248/cpb.c14-00694.
4
The stability of 5-aminolevulinic acid and its ester derivatives.
Acta Pol Pharm. 2004 Jan-Feb;61(1):15-9.
5
Is 5-aminolevulinic acid involved in the hepatocellular carcinogenesis of acute intermittent porphyria?
Cell Mol Biol (Noisy-le-grand). 2002 Feb;48(1):17-26.
6
Biological activity of 5-aminolevulinic acid and its methyl ester after storage under different conditions.
J Photochem Photobiol B. 2007 May 25;87(2):67-72. doi: 10.1016/j.jphotobiol.2007.01.003. Epub 2007 Feb 4.
7
Development of a stable solution of 5-aminolaevulinic acid for intracutaneous injection in photodynamic therapy.
Lasers Med Sci. 2002;17(3):208-15. doi: 10.1007/s101030200030.
8
Analysis of pyrazine 2,5-dipropionic acid in 5-aminolevulinic acid-loaded urological and topical delivery vehicles: methodology and assay validation.
J Pharm Biomed Anal. 2005 Jan 4;36(5):1099-105. doi: 10.1016/j.jpba.2004.09.004.
9
Chemical instability of 5-aminolevulinic acid used in the fluorescence diagnosis of bladder tumours.用于膀胱肿瘤荧光诊断的5-氨基乙酰丙酸的化学不稳定性。
J Photochem Photobiol B. 1996 Jul;34(2-3):143-8. doi: 10.1016/1011-1344(96)07285-5.
10
Tagging of protonated Ala-Tyr and Tyr-Ala by crown ether prevents direct hydrogen loss and proton mobility after photoexcitation: importance for gas-phase absorption spectra, dissociation lifetimes, and channels.冠醚对质子化丙氨酸-酪氨酸和酪氨酸-丙氨酸的标记可防止光激发后直接的氢损失和质子迁移:对气相吸收光谱、解离寿命和通道的重要性。
J Phys Chem A. 2009 Aug 20;113(33):9277-85. doi: 10.1021/jp904053d.

引用本文的文献

1
Pathogenesis of acute encephalopathy in acute hepatic porphyria.急性肝性卟啉病急性脑病的发病机制。
J Neurol. 2023 May;270(5):2613-2630. doi: 10.1007/s00415-023-11586-5. Epub 2023 Feb 9.
2
Heterogeneous molecular behavior in liver tumors (HCC and CCA) of two patients with acute intermittent porphyria.两名急性间歇性血卟啉症患者肝肿瘤(HCC 和 CCA)中的异质分子行为。
J Cancer Res Clin Oncol. 2023 Jun;149(6):2647-2655. doi: 10.1007/s00432-022-04384-5. Epub 2022 Oct 16.
3
Role of 5-aminolevulinic acid in the salinity stress response of the seeds and seedlings of the medicinal plant Cassia obtusifolia L.
5-氨基乙酰丙酸在药用植物决明种子和幼苗盐胁迫响应中的作用
Bot Stud. 2013 Dec;54(1):18. doi: 10.1186/1999-3110-54-18. Epub 2013 Aug 23.
4
Intra-operative acidosis during 5-aminolevulinic acid assisted glioma resection.5-氨基酮戊酸辅助胶质瘤切除术中的术中酸中毒。
BMJ Case Rep. 2015 Apr 24;2015:bcr2014207904. doi: 10.1136/bcr-2014-207904.
5
Expression of murine 5-aminolevulinate synthase variants causes protoporphyrin IX accumulation and light-induced mammalian cell death.鼠 5-氨基酮戊酸合酶变体的表达导致原卟啉 IX 积累和光照诱导的哺乳动物细胞死亡。
PLoS One. 2014 Apr 9;9(4):e93078. doi: 10.1371/journal.pone.0093078. eCollection 2014.
6
Targeting the active site gate to yield hyperactive variants of 5-aminolevulinate synthase.靶向活性位点门以产生 5-氨基乙酰丙酸合酶的超活性变体。
J Biol Chem. 2010 Apr 30;285(18):13704-11. doi: 10.1074/jbc.M109.074237. Epub 2010 Mar 1.
7
Arg-85 and Thr-430 in murine 5-aminolevulinate synthase coordinate acyl-CoA-binding and contribute to substrate specificity.小鼠5-氨基乙酰丙酸合酶中的精氨酸-85和苏氨酸-430协同作用以结合酰基辅酶A,并有助于底物特异性。
Protein Sci. 2009 Sep;18(9):1847-59. doi: 10.1002/pro.195.
8
Simple formation of an abiotic porphyrinogen in aqueous solution.水溶液中无生命卟啉原的简单形成。
Orig Life Evol Biosph. 2009 Dec;39(6):495-515. doi: 10.1007/s11084-009-9168-3.